BCLI Stock Price Prediction

Brainstorm Cell Therapeutics Inc

Add to Watchlist

Advanced Chart

0.672

-0.498(-42.564%)1D

Overview
Forecast
Valuation
Earnings

Should I Buy Brainstorm Cell Therapeutics Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BCLI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

BCLI stock price ended at $0.6722 on Monday, after losing -2.56%

The Brainstorm Cell Therapeutics Inc stock price decreased by -2.56% on the last trading day (28 Jul 2025), dropping from 1.22 to 1.17. Throughout the last trading session, the stock experienced a fluctuation of 24.27% , ranging from a day low of $1.03 to a day high of 1.28. The price has declined in 6 of the last 10 days, resulting in a total change of 0.00% during this period. On the last day, trading volume decrease by 2.55M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.77M shares were traded, amounting to approximately 3.22M.

BCLI Technical Signals

BCLI(Brainstorm Cell Therapeutics Inc Corp) has 2 buy signals and 1 sell signal now. The current trend is uptrend starting from 2025-06-13. The total price change during this trend is +6.36%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of BCLI over the last 5 trading days is 849.64K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.

BCLI Moving Average Analysis

Brainstorm Cell Therapeutics Inc's overall moving average trend leans more bearish as of Monday, July 28, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $1.36, and $1.47. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.01, and $0.89. A break-down below any of these levels will issue sell signals.

BCLI Short Selling Analysis

The short sale ratio of Brainstorm Cell Therapeutics Inc(BCLI) as of 17 Jul 2025 is 16.73%, dropping from last trading day. With decreasing price from 1.20 to 1.17. The short sell activity indicate that short sellers may be anticipating price hit a bottom.

Technical Signal

Technical Signals Summary

Neutral

Sell

Buy

Moving Average

Swing

Negative

Stock Price Below SMA_5

Short Term

Positive

SMA_5 Above SMA_20

Mid Term

Positive

SMA_20 Above SMA_60

Long Term

Negative

SMA_60 Below SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

2 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 > 0

0.0168

Bullish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 > 0

0.00828

Bullish

1 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Moving Average

Price crosses below 20-day SMA

Bearish

BCLI Stock Forecast

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Month	Min. Price	Avg. Price	Max. Price	Potential ROI

No data

Unlock Free Stock Price Forecast

In 2026, Brainstorm Cell Therapeutics Inc (BCLI) is anticipated to change hands in a trading channel between $0.00 and $0.00.

Brainstorm Cell Therapeutics Inc Stock Forecast 2026

BCLI Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Brainstorm Cell Therapeutics Inc(BCLI), our algorithm predicts BCLI's 1-month price at $1.37, with an 22.64%upwardshift. Using a similarity score up to 95.18%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for Brainstorm Cell Therapeutics Inc (BCLI.O) stock, as of Sunday, June 1, 2025 , forecasts a 22.64% change over the next month, based on its high correlation with FCEL.O stock patterns. The similarity between their price movements over the analyzed periods is 95.18%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

BCLI

Future prediction

Up: 22.64%

FCEL

Up: 22.64%Similarity: 95.18%

Name

Similarity

Up/Down

FCEL.O

95.18%

+22.64%

BIRK.N

94.91%

-0.97%

ADCT.N

94.24%

-43.98%

AX.N

94.02%

+3.12%

LNW.O

93.88%

-11.41%

NTES.O

93.85%

-26.90%

LUMN.N

93.81%

-8.17%

MSTR.O

93.80%

+25.92%

APOG.O

93.72%

-0.02%

BK.N

93.70%

-10.15%

BCLI Seasonality Analysis

Based on BCLI's historical stock price data across all years, the probability of a positive return in July is63.64%, suggesting it maybe an ideal month to invest in BCLI. In contrast,Marchoffers the highest probability of positive returns at63.64%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Brainstorm Cell Therapeutics Inc (BCLI.O) stock in March has the highest probability of a positive return (63.64%), while August has the lowest probability (10.00%).

Performance Seasonality

The chart shows Brainstorm Cell Therapeutics Inc. (BCLI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.